United States · Investor

H.I.G. BioVentures

Last cheque observed Aug 2015. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund, Dec 2010Growth equityWebsite unconfirmed

GrowthPharmaBiotechMedical Devices

Cheques on record
0%of best year0cheques in 12 months, 10 on record
Since the last cheque4086days00hrs00min00sec
Median round$19MRounds led0 of 10Mostly inUnited States, 100%
Pitch H.I.G. BioVentures

H.I.G. BioVentures highlights

  1. 01

    10 rounds on record

  2. 02

    Mostly Series A and Series B: 60% of its rounds

What they do

Type
Growth equity
Cheque size
Not stated
Stages
Growth
Sectors
PharmaBiotechMedical Devices
Based in
Miami, United States
Cold pitches
Not accepted

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first10 appearances

  1. 2015

    5 rounds

  2. Aug
    Orbus TherapeuticsSeries A · US$33MWith 3 others
  3. Jun
    Calhoun VisionVenture · US$52MWith 3 others
  4. Jun
    Calhoun VisionDebt · US$17MWith 3 others
  5. May
    NeuWave MedicalSeries C · US$25MWith 1 other
  6. May
    Intact VascularSeries B · US$38MWith 2 others
  7. 2014

    2 rounds

  8. Apr
    Iconic TherapeuticsSeries B · US$20MWith 2 others
  9. Apr
    ForSight LabsSeries C · US$15MWith 3 others
  10. 2012

    3 rounds

  11. Oct
    CerephexSeries A · US · sec.gov$5.9MWith 2 others
  12. Sept
    NeuWave MedicalSeries B · US · finsmes.com$14MWith 1 other
  13. Sept
    Intact VascularSeries A · US · intactvascular.com$16MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration3 named

ATAnthony TamerCo-President and Director of the ManageriFiling they signed
RSRichard SiegelSecretary and General Counsel of the ManageriFiling they signed
SMSami MnaymnehCo-President and Director of the ManageriFiling they signed

We also hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What they claim to have backed

From their own portfolio page (on their website)

0 of 11 we have independently watched raise

Direct LendingEuropeGrowthH.I.G. CapitalInfrastructureLatin AmericaPrivate EquityReal EstateSecondariesSpecial SituationsWhitehorse Finance BDC

Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.

Who they invest alongside

The investors most often in the same rounds as H.I.G. BioVentures. A count of rooms they were both in, not a relationship either has claimed.

Quick answers about H.I.G. BioVentures

What does H.I.G. BioVentures invest in?

H.I.G. BioVentures invests most often at Series A and Series B (60% of the rounds on record), in sectors such as Pharma, Biotech and Medical Devices.

How active is H.I.G. BioVentures?

10 investments on record, 0 of them in the last 12 months. The most recent was in Aug 2015.

How big are H.I.G. BioVentures's cheques?

The median round it joins is $19M.

Does H.I.G. BioVentures lead rounds?

Rarely, if at all: none of its 10 investments on record names it as the lead.

Where does H.I.G. BioVentures invest?

Most of the companies it backs are in the United States (100%).

Is H.I.G. BioVentures investing now?

No investments in the last 12 months; the latest was in Aug 2015.

Who does H.I.G. BioVentures invest alongside?

Most often Longitude Capital (3 rounds together), Balance Point Capital (2 rounds together) and Quaker Partners (2 rounds together).

What kind of investor is H.I.G. BioVentures?

H.I.G. BioVentures is a growth equity firm based in Miami, United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it